Download The 2025 SITC Post-Conference Report
As drug developers navigate an increasingly competitive and evolving IO space, this report provides clear data-driven intelligence to help shape your 2026 portfolio pipeline and early discovery focus.
The Report Includes:
- A concise breakdown of scientific and clinical trends shaping the next wave of IO innovation
- The top targets being investigated for Bispecifics and Checkpoint inhibitors, as well as ADC-IO combinations, and Cancer Vaccines by therapeutic class
- A quantitative view of the SITC 2025 landscape, including the distribution of >360 abstracts by disease indication, drug status and trial phase
You May Also Be Interested In…
Learn More About Oncology
What is Beacon Oncology?
- The Most Comprehensive Way to Search the Oncology Drug Development Landscape: Unique search ontologies based on Oncology drug and trial characteristics
- Market Leading Approach to Oncology Preclinical & Clinical Data Curation: Manual curation of key Oncology research and development data points by Oncology research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Oncology company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
